11 companies

WuXi XDC Cayman

Market Cap: HK$71.8b

An investment holding company, operates as a contract research, development, and manufacturing organization in China, North America, Europe, and internationally.

2268

HK$57.10

7D

1.5%

1Y

36.3%

Biocytogen Pharmaceuticals (Beijing)

Market Cap: HK$38.5b

A biotechnology company, engages in the research and development of novel antibody-based drugs and pre-clinical research services in the People’s Republic of China, the United States, and internationally.

2315

HK$55.35

7D

0.6%

1Y

266.1%

RemeGen

Market Cap: HK$65.3b

A biopharmaceutical company, discovers, develops, produces, and commercializes biological drugs for the treatment of autoimmune, oncology, and ophthalmic diseases in Mainland China and the United States.

9995

HK$91.65

7D

-6.5%

1Y

354.8%

CanSino Biologics

Market Cap: HK$13.0b

Develops, manufactures, and commercializes vaccines in the People’s Republic of China.

6185

HK$31.88

7D

-9.4%

1Y

-5.1%

JBM (Healthcare)

Market Cap: HK$2.2b

An investment holding company, engages in the manufacture, marketing, distribution, and sale of branded healthcare and wellness products in Hong Kong, Macau, Mainland China, and internationally.

2161

HK$2.66

7D

-2.2%

1Y

47.0%

Consun Pharmaceutical Group

Market Cap: HK$13.6b

Researches and develops, manufactures, and sells Chinese medicines and medical contrast medium products in the People’s Republic of China.

1681

HK$16.19

7D

-6.5%

1Y

84.2%

Innovent Biologics

Market Cap: HK$143.2b

A biopharmaceutical company, engages in the research and development of antibody and protein medicine products in the People’s Republic of China, the United States, and internationally.

1801

HK$82.55

7D

-2.7%

1Y

111.4%

Beijing Tong Ren Tang Chinese Medicine

Market Cap: HK$6.6b

Engages in the manufacture, retail, and wholesale of healthcare products and Chinese medicine to wholesalers and individuals.

New

3613

HK$7.89

7D

-7.8%

1Y

-9.3%

Luye Pharma Group

Market Cap: HK$9.4b

Develops, produces, markets, and sells pharmaceutical products in the People’s Republic of China, the United States, Europe, and internationally.

2186

HK$2.36

7D

-6.3%

1Y

2.6%

Simcere Pharmaceutical Group

Market Cap: HK$29.3b

An investment holding company, engages in the research, development, manufacture, and sale of pharmaceutical products to distributors, pharmacy chains, and other pharmaceutical manufacturers in China.

2096

HK$11.33

7D

-7.0%

1Y

49.3%

China Medical System Holdings

Market Cap: HK$32.1b

An investment holding company, manufactures, sells, markets, and promotes pharmaceutical products in the People’s Republic of China.

New

867

HK$13.27

7D

-3.3%

1Y

76.9%